Analyzing...
Loading company...
Amrutanjan Health Care Ltd. engages in the manufacture and sale of ayurvedic and allopathic products. The company is headquartered in Chennai, Tamil Nadu and currently employs 647 full-time employees. The company went IPO on 2009-11-05. Its segments include OTC Products, Beverages and Others. The OTC Products segment is engaged in manufacturing products of pain management, congestion management and hygiene. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. Its pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint. Its women's hygiene products include Comfy Snug Fit, Comfy Snug Fit XL and Comfy Snug Fit ULTRA XL. Its beverages include Fruitnik and Fruitnik Electro+. The company also has other products category.
No significant concerns identified
Nothing flagged for monitoring
“Operates in Pharmaceuticals — Formulations & API.”
₹503 Cr revenue.
COGS 48.6%, employees 12.7%.
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 15.6%▲ | 10.3% |
| ROCE | 20.4%▲ | 13.7% |
| Net Margin | 11.1%▲ | 7.6% |
| EBITDA Margin | 16.2%▲ | 15.4% |
| Debt To Equity | 0.00x▼ | 0.15x |
Historical valuation data not available.
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹503 Cr +11.2% | ₹452 Cr +7.3% | ₹421 Cr +11.0% | ₹380 Cr -6.5% | ₹406 Cr +21.9% | ₹333 Cr +27.3% | ₹261 Cr +3.3% | ₹253 Cr |
| Other Income | ₹18 Cr -0.6% | ₹18 Cr +4.3% | ₹17 Cr +16.5% | ₹15 Cr -5.5% | ₹15 Cr +35.9% | ₹11 Cr +36.0% | ₹8 Cr +16.7% | ₹7 Cr |
| Total Income | ₹520 Cr +10.8% | ₹469 Cr +7.1% | ₹438 Cr +11.2% | ₹394 Cr -6.4% | ₹421 Cr +22.4% | ₹344 Cr +27.6% | ₹270 Cr +3.6% | ₹260 Cr |
| COGS | ₹244 Cr +9.5% | ₹223 Cr +5.4% | ₹212 Cr +16.4% | ₹182 Cr +0.8% | ₹180 Cr +28.7% | ₹140 Cr +19.7% | ₹117 Cr -1.5% | ₹119 Cr |
| ₹433 Cr +8.2% | ₹400 Cr +6.4% | ₹376 Cr +10.5% | ₹341 Cr +3.0% | ₹331 Cr +26.1% | ₹262 Cr +11.4% | ₹235 Cr +4.5% | ₹225 Cr | |
| Profit Before Tax | ₹78 Cr +12.7% | ₹69 Cr +11.6% | ₹62 Cr +15.5% | ₹54 Cr -40.8% | ₹91 Cr +10.6% | ₹82 Cr +137.7% | ₹34 Cr -2.0% | ₹35 Cr |
| Exceptional Items | (₹9 Cr) | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
| ₹20 Cr +9.1% | ₹18 Cr +7.8% | ₹17 Cr +22.9% | ₹14 Cr -40.9% | ₹23 Cr +12.9% | ₹21 Cr +121.1% | ₹9 Cr -7.9% | ₹10 Cr | |
| Net Profit | ₹58 Cr +13.9% | ₹51 Cr +13.0% | ₹45 Cr +12.9% | ₹40 Cr -40.7% | ₹67 Cr +9.8% | ₹61 Cr +143.9% | ₹25 Cr +2.3% | ₹25 Cr |
| Other Comprehensive Income | (₹0.14 Cr) +82.5% | (₹0.79 Cr) ↓ Decline | ₹0.15 Cr ↑ Recovery | (₹1 Cr) -91.0% | (₹0.64 Cr) | (₹0.03 Cr) +90.5% | (₹0.29 Cr) +48.1% | (₹0.57 Cr) |
| EPS | ₹20.03 | ₹17.58 | ₹15.56 | ₹13.63 | ₹22.99 | ₹20.93 | ₹8.58 | ₹8.39 |
| Diluted Shares | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
No earnings call transcripts available.
Amrutanjan Health Care Limited has informed the Exchange about Action(s) taken or orders passed
Amrutanjan Health Care Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Amrutanjan Health Care Limited has informed the Exchange regarding 'Financial Results-Machine Readable Format'.
Amrutanjan Health Care Limited has informed the Exchange about Investor Presentation
Amrutanjan Health Care Limited has informed the Exchange that Board of Directors at its meeting held on May 08, 2026, recommended Final Dividend of Rs. 2.90 per equity share.
Amrutanjan Health Care Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Amrutanjan Health Care Limited has informed the Exchange about Product launch
Amrutanjan Health Care Limited has informed the Exchange regarding 'Rephrasing of ESOP'.
Amrutanjan Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Amrutanjan Health Care Limited has informed the Exchange about Action(s) initiated or orders passed
Amrutanjan Health Care Limited has informed the Exchange about General Updates
The Exchange has sought clarification from Amrutanjan Health Care Limited with respect to recent news item captioned Amrutanjan held Mylapore Kapaleeswarar Temple land till 2018; Rs 9.74 crore dues: H...
Amrutanjan Health Care Limited has informed the Exchange about Investor Presentation
Amrutanjan Health Care Limited has informed the Exchange that Record date for the purpose of Dividend is 07-Feb-2026.
Amrutanjan Health Care Limited has informed the Exchange that Board of Directors at its meeting held on February 03, 2026, declared Interim Dividend of Re. 1 per equity share.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.